Search
for
Sort by
Research 691–720 of 1000+
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Interleukin-10-deficient Mice Are Less Susceptible to the Induction of Alopecia Areata
- Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
- LB923 A matched cohort study evaluating the risk of keloid development in alopecia areata patients
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- New Modalities in the Treatment of Refractory Alopecia Areata
- Serum level of vitamin D in patients with alopecia areata
- Recent advances in the genetics of alopecia areata
- Osteopontin: a new facilitating factor in alopecia areata pathogenesis?
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Osteopontin Gene Polymorphisms rs1126616 C>T and rs1126772 A>G are Associated with Atopic Dermatitis in Polish Population
- Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Serum Vitamin D Level in Pediatric Alopecia Areata
- The Role of Vitamin D in Autoimmune Thyroid Diseases: From Immunomodulation to Clinical Implications
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Immune therapies for alopecia areata: evidence and new perspectives
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome
- Cardiovascular Disease-Associated Skin Conditions
- Dermal lymphatic dilation in a mouse model of alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions